MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to represent a sustainable long-term revenue generator.

Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the development of a cancer vaccine.

Larry Ellison unveiled plans for an AI-driven cancer vaccine system that could deliver personalized treatments within 48 hours.

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

Grail (GRAL) is jumping for a second straight day, climbing 6% today, after Oracle (ORCL) Chairman Larry Ellison on Tuesday said that blood tests that detect small tumor fragments could be used, in combination with AI and gene sequencing,

US tech titans Elon Musk, Mark Zuckerberg and Jeff Bezos are taking a prominent place in the new Trump era, but another player from another era -- Oracle boss Larry Ellison -- is making a surprise return.

Oracle chairman and chief technology officer Larry Ellison joins President Trump to discuss the U.S. Stargate investment.

Shares of Austin, Texas-based Oracle Corp. (ORCL) are on track to open at their highest level since early December after the company joined an OpenAI-led artificial intelligence (AI) joint venture named Stargate,

With multiple suitors circling and Trump framing the situation as a deal-making exercise, TikTok's U.S. future is still up in the air. If a resolution is reached, it could set a precedent for tech ownership disputes between the U.

WASHINGTON (Reuters) - U.S. President Donald Trump on Thursday dismissed criticism from close ally Elon Musk about a $500 billion artificial intelligence project that Trump announced with great fanfare at the White House earlier this week.

The market's reaction to the news about Project Stargate was very positive with ARM's stock skyrocketing by as much as 16%. Read my analysis.